Related references
Note: Only part of the references are listed.Diabetes and cancer risk: A Mendelian randomization study
Atsushi Goto et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Positive effect of metformin treatment in colorectal cancer patients with type 2 diabetes: national cohort study
Audrius Dulskas et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2020)
Impact of diabetes on colorectal cancer stage and mortality risk: a population-based cohort study
Judy K. Qiang et al.
DIABETOLOGIA (2020)
Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses
Neil Murphy et al.
GASTROENTEROLOGY (2020)
Multimorbidity and short-term overall mortality among colorectal cancer patients in Spain: A population-based cohort study
Miguel A. Luque-Fernandez et al.
EUROPEAN JOURNAL OF CANCER (2020)
Mitochondria Participate in Chemoresistance to Cisplatin in Human Ovarian Cancer Cells
Luca X. Zampieri et al.
MOLECULAR CANCER RESEARCH (2020)
Loss of the nuclear Wnt pathway effector TCF7L2 promotes migration and invasion of human colorectal cancer cells
Janna Wenzel et al.
ONCOGENE (2020)
Relationship between metformin therapy and risk of colorectal cancer in patients with diabetes mellitus: a meta-analysis
Wen-Tao Yang et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2020)
Diabetes mellitus and colorectal carcinoma outcomes: a meta-analysis
Daniel J. Becker et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2020)
Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression
Cheng-Ann Winston Ng et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2020)
Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)
Justin C. Brown et al.
JNCI CANCER SPECTRUM (2020)
Impact of diabetes comorbidity on the efficacy and safety of FOLFOX first-line chemotherapy among patients with metastatic colorectal cancer: a pooled analysis of two phase-III studies
O. Abdel-Rahman
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Epigenetics in Human Obesity and Type 2 Diabetes
Charlotte Ling et al.
CELL METABOLISM (2019)
The TCF7L2 Locus: A Genetic Window Into the Pathogenesis of Type 1 and Type 2 Diabetes
Struan F. A. Grant
DIABETES CARE (2019)
The Potential Effect of Metformin on Cancer: An Umbrella Review
Hong Yu et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Global Trends in Type 2 Diabetes, 2007-2017
Joan Williams et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Metformin Is Associated With Reduced Odds for Colorectal Cancer Among Persons With Diabetes
Joshua Demb et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis
Claudio Vernieri et al.
ONCOLOGIST (2019)
Non-Coding RNAs in IGF-1R Signaling Regulation: The Underlying Pathophysiological Link between Diabetes and Cancer
Baoqing Chen et al.
CELLS (2019)
Anticancer activity of metformin: a systematic review of the literature
Mohamad Aljofan et al.
FUTURE SCIENCE OA (2019)
High blood sugar levels but not diabetes mellitus significantly enhance oxaliplatin chemoresistance in patients with stage III colorectal cancer receiving adjuvant FOLFOX6 chemotherapy
I-Ping Yang et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials
Thomas Aparicio et al.
EUROPEAN JOURNAL OF CANCER (2018)
Association between metformin use after surgery for colorectal cancer and oncological outcomes: A nationwide register-based study
Tina Fransgaard et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Diabetes, plasma glucose and incidence of colorectal cancer in Chinese adults: a prospective study of 0.5 million people
Yuanjie Pang et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2018)
Dose-Dependent Relationship Between Metformin and Colorectal Cancer Occurrence Among Patients with Type 2 Diabetes-A Nationwide Cohort Study
Yu-Tang Chang et al.
TRANSLATIONAL ONCOLOGY (2018)
miR-16-5p inhibits chordoma cell proliferation, invasion and metastasis by targeting
Hongliang Zhang et al.
CELL DEATH & DISEASE (2018)
撤稿声明: 被撤回的出版物: Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment (Retraction of Vol 6, Pg 95, 2018) (Retracted article. See vol. 6, pg. 95, 2018)
Jonathan Pearson-Stuttard et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology
Shuji Ogino et al.
Annual Review of Pathology-Mechanisms of Disease (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Type 2 diabetes and risk of colorectal cancer in two large US prospective cohorts
Yanan Ma et al.
BRITISH JOURNAL OF CANCER (2018)
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017
Gregory A. Roth et al.
LANCET (2018)
Metformin and Colorectal Cancer
Takuma Higurashi et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer
Gerald Davies et al.
PLOS ONE (2017)
A functional variant in GREM1 confers risk for colorectal cancer by disrupting a hsa-miR-185-3p binding site
Jiaoyuan Li et al.
ONCOTARGET (2017)
2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications
Nieves Gonzalez et al.
ONCOTARGET (2017)
Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis
Fanqiang Meng et al.
JOURNAL OF DIABETES RESEARCH (2017)
The relationship between diabetes and colorectal cancer prognosis: A meta-analysis based on the cohort studies
Bo Zhu et al.
PLOS ONE (2017)
Association Among Obesity, Metabolic Health, and the Risk for Colorectal Cancer in the General Population in Korea Using the National Health Insurance Service-National Sample Cohort
Cheol Min Shin et al.
DISEASES OF THE COLON & RECTUM (2017)
Risk factors for cancer development in type 2 diabetes: A retrospective case-control study
Mariusz Dabrowski et al.
BMC CANCER (2016)
Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer
Sander de Kort et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Incidence of Diabetes in Colorectal Cancer Survivors
Simron Singh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial
Takuma Higurashi et al.
LANCET ONCOLOGY (2016)
Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)
Preet Paul Singh et al.
ONCOLOGIST (2016)
High blood sugar levels significantly impact the prognosis of colorectal cancer patients through down-regulation of microRNA-16 by targeting Myb and VEGFR2
I-Ping Yang et al.
ONCOTARGET (2016)
Association between markers of glucose metabolism and risk of colorectal cancer
Jinming Xu et al.
BMJ OPEN (2016)
Incidence of Diabetes in Colorectal Cancer Survivors
Simron Singh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
A Linear Dose-Response Relationship between Fasting Plasma Glucose and Colorectal Cancer Risk: Systematic Review and Meta-analysis
Jianguo Shi et al.
SCIENTIFIC REPORTS (2015)
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Konstantinos K. Tsilidis et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Konstantinos K. Tsilidis et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Metformin for Primary Colorectal Cancer Prevention in Patients With Diabetes: A Case-Control Study in a US Population
Amikar Sehdev et al.
CANCER (2015)
Cancer Risk Among People With Type 1 and Type 2 Diabetes: Disentangling True Associations, Detection Bias, and Reverse Causation
Jessica L. Harding et al.
DIABETES CARE (2015)
Human Genetics Shape the Gut Microbiome
Julia K. Goodrich et al.
CELL (2014)
High Glucose Modulates Antiproliferative Effect and Cytotoxicity of 5-Fluorouracil in Human Colon Cancer Cells
Yi-Shing Ma et al.
DNA AND CELL BIOLOGY (2014)
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
Timothy Robert Church et al.
GUT (2014)
miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy
Jin-Yang Wang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
High Frequency of Fusion Transcripts Involving TCF7L2 in Colorectal Cancer: Novel Fusion Partner and Splice Variants
Torfinn Nome et al.
PLOS ONE (2014)
Meta-Analysis of Genome-Wide Association Studies in African Americans Provides Insights into the Genetic Architecture of Type 2 Diabetes
Maggie C. Y. Ng et al.
PLOS GENETICS (2014)
Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer
K. M. J. de Bruijn et al.
BRITISH JOURNAL OF SURGERY (2013)
Antidiabetic Medications and the Risk of Colorectal Cancer in Patients with Diabetes Mellitus: A Systematic Review and Meta-analysis
Siddharth Singh et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
A Cohort Study of Metformin Exposure and Survival in Patients with Stage I-III Colorectal Cancer
Susan Spillane et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Diabetes Mellitus and the Occurrence of Colorectal Cancer: An Updated Meta-Analysis of Cohort Studies
Lei Wu et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2013)
Diabetes Mellitus and Colorectal Cancer Prognosis: A Meta-analysis
Katherine T. Mills et al.
DISEASES OF THE COLON & RECTUM (2013)
Adult weight change and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition
Krasimira Aleksandrova et al.
EUROPEAN JOURNAL OF CANCER (2013)
Impact of Diabetes on Oncologic Outcome of Colorectal Cancer Patients: Colon vs. Rectal Cancer
Justin Y. Jeon et al.
PLOS ONE (2013)
Large-Scale Gene-Centric Meta-Analysis across 39 Studies Identifies Type 2 Diabetes Loci
Richa Saxena et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Diabetes Mellitus and the Incidence of Colorectal Cancer: An Updated Systematic Review and Meta-Analysis
Longying Deng et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field
Shuji Ogino et al.
GUT (2011)
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Sreenivasa Rao Kondapally Seshasai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies
R. K. Ramanathan et al.
ANNALS OF ONCOLOGY (2010)
Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial
Kunihiro Hosono et al.
CANCER PREVENTION RESEARCH (2010)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk
Aditi Hazra et al.
CANCER CAUSES & CONTROL (2008)
Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria
K Rapp et al.
DIABETOLOGIA (2006)
Diabetes mellitus and risk of colorectal cancer: A meta-analysis
SC Larsson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Type 2 diabetes mellitus and the risk of colorectal cancer
YX Yang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
AG Renehan et al.
LANCET (2004)
A pancreatic islet-specific microRNA regulates insulin secretion
MN Poy et al.
NATURE (2004)
Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis
TIL Nilsen et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
